Finance

Lists
1AFX:BIT
Carl Zeiss Meditec AG
31,20 €
+0,45%
(+0,14) 1D
2 қаз., 17:26:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1AFX...
Open
31,20 €
High
31,20 €
Low
31,20 €
Mkt. cap
2,86 млрд
Avg. vol.
39,00
Volume
15,00
Dividend
1,76%
Quarterly dividend
0,14 €
Ex-dividend date
2026 ж. 27 нау.
P/E ratio
22,71
52-wk high
48,30 €
52-wk low
22,88 €
EPS
1,37 €
No. of employees
6 мың
Open
31,20 €
High
31,20 €
Low
31,20 €
Mkt. cap
2,86 млрд
Avg. vol.
39,00
Volume
15,00
Dividend
1,76%
Quarterly dividend
0,14 €
Ex-dividend date
2026 ж. 27 нау.
P/E ratio
22,71
52-wk high
48,30 €
52-wk low
22,88 €
EPS
1,37 €
No. of employees
6 мың
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
41 минут бұрын
Why Acadia Pharmaceuticals Bears Were Right Before The Drop
Seeking Alpha
Seeking Alpha
·
4 сағат бұрын
S&P 500 Index Concentration - Room At The Top
Profile
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications. Wikipedia
About Carl Zeiss Meditec AG
CEOMarkus Weber
Employees5,8 мың
Founded2002
HeadquartersЙена, Тюрингия, Германия
SectorMedical device
Websitezeiss.com
Last report
2026 ж. 06 там.
Fiscal period
Q3 2026
0,54 € / 0,40 €
+35,00%beat
Revenue / Est. (EUR)
562,72 млн / 540,72 млн
+4,07%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
627,54 млн
467,00 млн
524,00 млн
562,72 млн
Cost of goods sold
295,75 млн
239,80 млн
260,62 млн
260,44 млн
Cost of revenue
295,75 млн
239,80 млн
260,62 млн
260,44 млн
Research and development expenses
91,78 млн
75,50 млн
89,30 млн
78,94 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169,64 млн
152,00 млн
150,59 млн
162,39 млн
Operating expense
261,40 млн
227,50 млн
237,90 млн
240,02 млн
Total operating expenses
557,15 млн
467,30 млн
498,52 млн
500,46 млн
Operating income
70,40 млн
-300,00 м.
25,48 млн
62,26 млн
Other non operating income
-4,02 млн
-200,00 м.
4,27 млн
7,88 млн
EBT including unusual items
67,29 млн
-5,50 млн
25,79 млн
69,16 млн
EBT excluding unusual items
62,61 млн
-5,50 млн
25,79 млн
69,16 млн
Income tax expense
13,05 млн
200,00 м.
6,76 млн
16,40 млн
Effective tax rate
19,39%
-3,64%
26,21%
23,71%
Other operating expenses
-17,00 мың
-
-1,99 млн
-1,31 млн
Net income
51,81 млн
-4,90 млн
19,57 млн
55,03 млн
Net profit margin
8,26%
-1,05%
3,73%
9,78%
Earnings per share
-
0,03
0,45
0,54
Interest and investment income
570,00 м.
1,20 млн
1,28 млн
2,09 млн
Interest expense
-6,30 млн
-6,00 млн
-6,16 млн
-5,93 млн
Net interest expenses
-5,73 млн
-4,80 млн
-4,88 млн
-3,84 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
83,01 млн
12,31 млн
63,70 млн
74,87 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары